1. Home
  2. HOVR vs IFRX Comparison

HOVR vs IFRX Comparison

Compare HOVR & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Horizon Aircraft Ltd.

HOVR

New Horizon Aircraft Ltd.

HOLD

Current Price

$1.75

Market Cap

103.1M

Sector

Finance

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$1.09

Market Cap

86.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOVR
IFRX
Founded
2013
2007
Country
Canada
Germany
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.1M
86.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
HOVR
IFRX
Price
$1.75
$1.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$6.50
$8.50
AVG Volume (30 Days)
1.1M
7.7M
Earning Date
01-13-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$73,729.00
Revenue This Year
N/A
N/A
Revenue Next Year
$55.08
$1,075.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$0.71
52 Week High
$4.18
$2.82

Technical Indicators

Market Signals
Indicator
HOVR
IFRX
Relative Strength Index (RSI) 47.47 42.21
Support Level $1.16 $0.92
Resistance Level $1.69 $1.28
Average True Range (ATR) 0.17 0.11
MACD 0.06 -0.02
Stochastic Oscillator 77.22 30.42

Price Performance

Historical Comparison
HOVR
IFRX

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: